Viridian Capital Advisors are among the most trusted sources for Cannabis/Hemp Industry Capital, M&A and Strategic Information. Here are just a few mentions...
Year-To-Date, Cannabis REITs Provide Key Source of Financing for Businesses
In 2022, falling equity prices have had a chilling effect on capital raises, particularly on large equity issues, which have been confined to non-plant-touching sectors.
Why Weed Companies Can't Make Any Money
The legal marijuana business is booming - revenues are projected to hit $32 billion this year, more than double what sales were three years ago... But that hasn’t prevented most weed companies from continuing to hemorrhage red ink...
These Are The Most Important Investors In The Cannabis Industry
Despite regulatory hurdles, the experienced and engaged cannabis investors nominated for this year's Benzinga Cannabis Investors Award are making it possible for everyone to tap into the market's potential.
What are Angel Investors Looking for in the Cannabis Industry?
The startup nature of the cannabis industry has attracted angel investors as a key source of early stage capital for emerging private cannabis companies. This article examines the angel investor in cannabis and how this type of investor has evolved.
Meet Viridian Capital CEO Scott Greiper at Benzinga's Cannabis Conference
At the upcoming Benzinga Capital Cannabis Conference Sept 13-14 in Chicago, attendees will have the opportunity to learn from the important executives of the industry, including Scott Greiper, President and Founder of Viridian Capital Advisors, the first investment bank in the cannabis space.
Will a shift from private equity help you?
As recently as 2018, cultivation- and retail-sector financing was almost exclusively the domain of private companies, according to data from the Viridian Deal Tracker. But public debt financing has been taking a bigger role recently.
Cannabis Stocks May Fall More In 2022, But Rise In ‘23, ‘24
After a miserable year for the cannabis sector, one Wall Street firm focused on the industry said investors should prepare for more of the same in 2022. Viridian Capital Advisors, a New York financial and strategic advisory firm dedicated to the cannabis market, released a report this month outlining its predictions for the U.S. cannabis market.
14 Founder-Friendly Investment Firms Pioneering The Cannabis Space
Benzinga highlights some of the major players in the cannabis investment space that are set to shake up the cannabis industry.
EXCLUSIVE: Scott Greiper, President of Viridian Capital Advisors, Sits Down With MJBulls To Speak About Cannabis Investing
The Cannabis Investor Series Sponsored by TWO12 is back for the Fourth year. This year, the Series will feature eighteen of the cannabis industry's top investors, reviewing the previous 12-months and sharing their 2022 investment strategies. On today's episode Dan Humiston is joined by Scott Greiper, President of Viridian Capital Advisors.
EXCLUSIVE: Viridian Capital's Scott Greiper On Increasing M&A In Cannabis Space, Trends, SPAC Opportunities
Lowered valuations for cannabis companies are leading to a shift in the way capital raises and merger and acquisition activity is occurring in the cannabis space. Viridian Capital Advisors President & Founder Scott Greiper shared the trends that are shifting in the space.
Outperforming Cannabis Stocks Without Federal Legislation: These Top MSO Picks Will Surprise You
With this note, we highlight our top picks amongst the biggest MSOs and smaller operators that are best positioned for outperforming stock returns through execution on growth initiatives and takeout. We also identify five unfollowed names in the space that can offer outsized returns on greater awareness and continued execution.
Cannabis Market 2021: US Marijuana Companies Dominate Deal Volume, Raising Capital Faster Than Canadians
The graph displays the volume of capital raises and number of acquisitions Canadian and U.S. companies have completed from 2018-2021 YTD.
Cannabis Stock Performance Since The Schumer/Booker Proposal
The best performing stock group over most of the period (down 14.1%) were the large Canadian LPs. This group would be the biggest gainer from a full federal legalization scenario, which we believe is unlikely to occur over the next one to two years.
The 9 little-known cannabis stocks to bet on now to profit from the sector's pullback, according to a top Wall Street Analyst
Cannabis stocks have been slumping after hitting a peak in February. That may mean big opportunities for investors to get in at low prices.
British American Tobacco's Btomorrow Ventures Leads $25.4M Series A For Cannabinoid Biotech Co. Trait Bio
Trait Biosciences, a leading cannabinoid biotechnology research organization, announced that it has completed a C$31 million ($25.46 million) Series A financing round led by the corporate venturing unit of British American Tobacco (NYSE:BTI), Btomorrow Ventures, and backed by Gotham Green Partners.
Can You Get Rich From Cannabis?
Meanwhile, the number of states legalizing cannabis is growing every year. Sixteen total states have legalized recreational cannabis (three of which went legal just this year), and 36 states have legalized medical marijuana.
One of the Pot Industry's Best Highs is Fading
A big listed U.S. cannabis grower recently raised debt at a sub-10% coupon for the first time. It isn’t a positive sign for everyone.
Here Are 3 Cannabis Stocks to Consider as They Face Significant Debt Issues
As most cannabis company stocks have risen in valuation over the past six months, it's worth looking at those that haven't.
Cannabis Companies Are Ready to Roll
Strong sales during the pandemic and the Senate flip are easing some of the sector's old challenges.
Cannabis Movers & Shakers: Vireo Health, Flora, MJardin, Arcview, Viridian Capital Advisors
Here is a summary of the latest leadership changes within the cannabis industry.
Investors Have Poured Almost $3 Billion into Cannabis SPACs
Click here to view "Investors have poured almost $3 billion into Cannabis SPACs". This article was written based off an interview with Viridian's Founder and CEO, Scott Greiper.
Viridian Chart Of The Week: Sector Rotation In Cannabis M&A Activity
Since the beginning of the Viridian Deal Tracker in 2015, the Cultivation & Retail Sector has always dominated M&A transaction volumes. However, in 2020 we have seen an increase in 3 other sectors: Infused Products, Biotech/Pharma and Software/Media.
Synthetic Psilocybin Treatments by 2025
THC focused stocks in 2020 have fared better than CBD ones, according to Viridian Capital Advisors, which compared a handful of cannabis company stocks in the first 40 weeks of 2020.
Pot Stocks Go on a Chilled-Out Election Rally
A victory for the Democratic Party in next month’s presidential election would be a game changer for the cannabis industry. Despite their reputation for over-exuberance, pot investors are reacting with level heads.
Read The Viridian Cannabis Deal Tracker Report For The First Half Of 2020
Viridian Capital Advisors is proud to announce the release of the 1st Half Viridian Cannabis Deal Tracker Report. Please click below to access the report.
SPACs Offer Marijuana Companies A Source Of Funding - And A Way To Go Public
A meteoric rise in cannabis special purpose acquisition companies – better known as SPACs – is providing private marijuana and hemp companies an unprecedented opportunity to raise money and go public.
Cannabis Companies Secure Fresh Funding Deals As Investors Wade Back Into Capital Markets
Marijuana businesses have raised hundreds of millions of dollars in recent months, a trend that is expected to continue as an investment dry spell that began late last year appears to be easing.
Real Estate Sale-Leaseback Transactions Free Up Capital For Cannabis Operators
Over the past year the cannabis sector experienced its first sustained contraction in capital markets transactions and capital availability. Here are the numbers according to the Viridian Cannabis Deal Tracker. In 2019 the number of capital raises declined by 12.6% and the total capital raised fell by 17.8%. So far in 2020, the decline has been even more significant. Through the first 8 months of 2020, the number of capital raises fell by 52.5% and the total dollars raised compared to the same period in 2019.
Federal Antitrust Investigations Into Cannabis M&A Deals Now Are Under the Microscope Themselves
The Federal Trade Commission and the U.S. Department of Justice (DOJ) Antitrust Division have taken great interest in recent cannabis deals—especially blockbuster transactions along the lines of acquisition of Cannabis is still illegal, but the feds are beginning to enforce their rules.
Data: Year-To-Date Cannabis Capital Raises Down 70% Year-Over-Year
The Viridian Cannabis Deal Tracker* provides the deal data/terms/valuations/structures and market intelligence that cannabis companies, investors, and acquirers utilize to make informed decisions regarding capital and M&A strategy.
Week 32: August 3rd, 2020 - August 7th, 2020
LeafLink Debt Deal Shows Cannabis Entering a New Phase
Marijuana stocks rode highs from late 2017 to 2018, as investors sought to enter the budding business that was emerging from prohibition as states relaxed their laws. But the market tumbled over the past year as that optimism faded amid challenges that include a patchwork of state regulations and no access to traditional banking services.
Data: Cannabis Capital Raises And M&A Slowing Down Sharply
The Viridian Cannabis Deal Tracker* provides the deal data/terms/valuations/structures and market intelligence that cannabis companies, investors, and acquirers utilize to make informed decisions regarding capital and M&A strategy.
Week 29: July 13th, 2020 - July 17th, 2020
Two Large Financing Deals Lift Cannabis Capital Raises Above $2.5B For 2020
The Viridian Cannabis Deal Tracker* provides the deal data/terms/valuations/structures and market intelligence that cannabis companies, investors, and acquirers utilize to make informed decisions regarding capital and M&A strategy.
Week 25: June 15th, 2020 - June 19th, 2020
Data: Cannabis Capital Raises Pick Up In June As Public Companies Get New Money
For the first time in 2020 we saw more dollars raised and a higher average tranche size than in the same week during 2019.
Cannabis SPACs Are the Only Game in Town
With over $2.5 billion raised by SPACs in the cannabis industry, there is more buying power in the market that is fueling new M&A activity.
Has Big Cannabis Lost Its Buzz? Marijuana Stocks Suffer As Markets Experience A Correction
It’s no secret that the legal cannabis industry has been taking it on the chin lately, with stock prices falling after years of very high valuations, almost never justified by companies’ fundamentals.
Data: June Cannabis Capital Raises Off To A Slow Start
The Viridian Cannabis Deal Tracker* provides the deal data/terms/valuations/structures and market intelligence that cannabis companies, investors, and acquirers utilize to make informed decisions regarding capital and M&A strategy.
Week 23: June 1st, 2020 - June 5th, 2020
Has Big Cannabis Lost Its Buzz? Marijuana Stocks Suffer As Markets Experience A Correction
It’s no secret that the legal cannabis industry has been taking it on the chin lately, with stock prices falling after years of very high valuations, almost never justified by companies’ fundamentals.
3 “Strong Buy” Cannabis Stocks Set to Benefit From Mergers
The cannabis sector has run into major liquidity issues with the lack of access to the banking system in the U.S. and market issues in Canada.
Cannabis Companies Brace For Defensive Mergers In 2020
The struggling cannabis sector is likely to see a wave of large and mid-sized mergers in 2020 as growth capital goes up in smoke, stock prices decline and producers report lower-than-expected sales, industry executives say.
The Cannabis Biz is Down, but Long Term it’s Smoking
With the cannabis industry reeling from a series of setbacks over the last six months, the marijuana business conference began in Las Vegas on Monday with an investors’ meet-up marked by existential distress.
Deals Dry Up with Pot Stocks Limping Into Year End
Dealmaking has gone quiet in the marijuana space as the slump in shares removes a vital currency and investors get picky.
Marijuana Stocks: Canopy Growth Joins Forces With Drake
Canopy Growth on Thursday launched a cannabis wellness company with rapper Drake, the latest weed-related tie-up with a celebrity, even as investor sentiment sours on the industry.
Pot Companies Shed Real Estate Amid Dearth of Financing Options
With pot illegal federally in the U.S., many companies in the industry struggled to find landlords willing to rent space and ended up owning property.
The Pot Industry Is Scrambling for Cash
The North American Marijuana Index, which tracks the leading cannabis stocks in the U.S. and Canada, has fallen more than 52% in the past 12 months.
Meet the banks that are leading the flourishing deal market for pot stocks
Amid the recent volatility in pot stocks, there is one group that appears to be capitalizing on the cannabis industry: the banks advising on a flourishing deal market for these companies.
Breaking down the big deal behind Constellation’s bet and Wall Street’s involvement
Constellation Brands’ multibillion-dollar wager on Canopy Growth is huge – record setting even – but a much larger story is lighting up across the cannabis industry: Wall Street has arrived.
Going Public: What’s the Best Option for Your Cannabis Business?
In an IPO, companies sell shares to the public via a stockbroker. In an RTO, a business buys enough shares to control a publicly traded “shell,” then exchanges shares in its private company for shares in that shell.
CFN Media Partners with Viridian Capital Advisors to Produce Monthly Video Series
The series, called CFN Media & Viridian's Cannabis Capital Markets Wrap, will be filmed at CFN Media's Los Angeles studios and feature the President of Viridian Capital, Scott Greiper, recounting the previous month's activity and trends in the cannabis markets.
Ways For Marijuana Firms to Protect Their Stocks From Short Sellers
Short sellers are betting heavily against the rapidly growing marijuana sector, especially the stocks of major players in the Canadian cannabis industry.
A Look at What's Ahead for the Cannabis Industry
The start to 2019 looks to be much more promising for the cannabis industry than last year. If you'll recall 2018 began with then Attorney General Jeff Sessions rescinding the Cole Memorandum.
Cannabis Companies Expect Big Growth After Trump Legalizes Hemp
The 2018 Farm Bill Trump signed earlier this month allows for hemp cultivation and the transfer of hemp-derived products across state lines for commercial or other purposes.
Cannabis Investments Nearly Quadrupled in 2018
Cannabis-related companies raised nearly $13.8 billion so far this year, compared to just $3.5 billion in 2017, according to data from Viridian Capital Advisors, a financial and strategic advisory firm for the cannabis industry.
*Marijuana remains illegal under federal law. The Federal Government does not recognize marijuana to have any medicinal values. Marijuana cultivation, possession, consumption, sales, and distribution are illegal under federal laws and also certain state laws. Please note that there are differences in marijuana laws from one state, county, or city to another.
Subscribe to Deal Tracker
Subscribe to receive the latest cannabis industry investment activity
